Daniel Roberts

Daniel Roberts focuses his practice on intellectual property litigation, with a focus on complex patent and trademark matters. He has argued before the U.S. Court of Appeals for the Federal Circuit and the U.S. District Court for the District of Delaware. Mr. Roberts has represented clients in bringing and defending against Lanham Act, trademark, unfair competition, and false association claims. Mr. Roberts has also represented numerous pharmaceutical companies in patent and antitrust litigation in federal court and before the Patent Trial and Appeal Board.

He was previously a research chemist in the pharmaceutical industry for nearly a decade, specializing in drug product design, high-throughput crystallization, small molecule and protein crystallography, and tech transfer. His research areas were virology (particularly HIV and HCV combination therapies), metabolic disorders, cardiovascular disorders and oncology (particularly PD1/PDL1). He is a named inventor on numerous patents and patent applications, including U.S. Patent No. 8,759,372 (Roberts et al.) directed to a crystal form of a CGRP antagonist. His writing has appeared in Reuters, JD Supra, NYIPLA: The Report, Law360 and Crystal Growth & Design.

Mr. Roberts maintains an active pro bono practice, working with veterans to secure government benefits in the Court of Appeals for Veterans’ Claims and the U.S. Court of Appeals for the Federal Circuit, as well as assisting victims of battery or extreme cruelty in obtaining lawful permanent residence in the U.S.